amantadine has been researched along with 7-methoxytacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drtinova, L; Gazova, Z; Horova, A; Korabecny, J; Kral, J; Kuca, K; Musilek, K; Siposova, K; Soukup, O; Spilovska, K | 1 |
| Drtinova, L; Fedunova, D; Gazova, Z; Hamouda, AK; Horak, M; Jost, P; Kaniakova, M; Korabecny, J; Kuca, K; Nepovimova, E; Sepsova, V; Siposova, K; Soukup, O; Spilovska, K; Wang, ZJ | 1 |
2 other study(ies) available for amantadine and 7-methoxytacrine
| Article | Year |
|---|---|
7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment--synthesis, biological evaluation and molecular modeling studies.
Topics: Acetylcholinesterase; Alzheimer Disease; Amantadine; Cholinesterase Inhibitors; Dimerization; Enzyme Assays; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Docking Simulation; Reference Standards; Tacrine; Thiourea | 2013 |
Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amantadine; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; CHO Cells; Cholinesterases; Cricetulus; Dimerization; Enzyme Inhibitors; HEK293 Cells; Humans; Molecular Targeted Therapy; Receptor, Muscarinic M1; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate; Tacrine; Xenopus | 2017 |